Humacyte, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Humacyte, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Humacyte, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$39.2M, a 50.8% decline year-over-year.
  • Humacyte, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$153M, a 71% decline year-over-year.
  • Humacyte, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$111M, a 826% decline from 2022.
  • Humacyte, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$12M, a 54.8% increase from 2021.
  • Humacyte, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$26.5M, a 60.2% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$153M -$39.2M -$13.2M -50.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$140M -$56.7M -$34M -150% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-08
Q1 2024 -$106M -$31.9M +$5.07M +13.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-08
Q4 2023 -$111M -$25.1M -$21.4M -575% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$89.4M -$26M -$714K -2.82% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$88.7M -$22.7M -$59.6M -162% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-08
Q1 2023 -$29.1M -$37M -$17.1M -86.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-08
Q4 2022 -$12M -$3.72M -$46.3M -109% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $34.3M -$25.3M +$6.28M +19.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $28.1M $36.9M +$54.1M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$26M -$19.8M +$469K +2.31% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$26.5M $42.6M +$58.8M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 -$85.3M -$31.6M -$13.8M -77.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$71.5M -$17.2M -$2.32M -15.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$69.2M -$20.3M -$2.63M -14.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$66.5M -$16.2M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$17.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$14.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$17.7M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.